The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance).
Debra L. Barton
No relevant relationships to disclose
Jeff A. Sloan
No relevant relationships to disclose
Lynne T Shuster
No relevant relationships to disclose
Paula Gill
No relevant relationships to disclose
James D. Bearden
No relevant relationships to disclose
David B Johnson
No relevant relationships to disclose
Philip J. Stella
No relevant relationships to disclose
Shelby A. Terstriep
No relevant relationships to disclose
Fauzia N. Rana
No relevant relationships to disclose
Daniel M. Anderson
No relevant relationships to disclose
Charles L. Loprinzi
No relevant relationships to disclose